Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle

Incidence and Clinical Significance of Parvovirus B19 Infection in Patients with Rheumatoid Arthritis

SVETLANA V. KOZIREVA, JEKATERINA V. ZESTKOVA, HELENA J. MIKAZANE, ANDA L. KADISA, NATALJA A. KAKURINA, AIVARS A. LEJNIEKS, IRENA N. DANILANE and MODRA F. MUROVSKA
The Journal of Rheumatology July 2008, 35 (7) 1265-1270;
SVETLANA V. KOZIREVA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: skozireva@latnet.lv
JEKATERINA V. ZESTKOVA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HELENA J. MIKAZANE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANDA L. KADISA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NATALJA A. KAKURINA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AIVARS A. LEJNIEKS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
IRENA N. DANILANE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MODRA F. MUROVSKA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

Abstract

Objective

To determine the prevalence and clinical significance of human parvovirus B19 (B19) infection in patients with rheumatoid arthritis (RA).

Methods

One hundred patients with RA and 94 apparently healthy blood donor controls were enrolled for study. Plasma samples of patients and controls were examined for the presence of anti-B19-specific antibodies by ELISA. B19 DNA was detected in plasma and peripheral blood leukocyte (PBL) samples of all patients and controls as well as in synovial fluid cells of 38 RA patients by nested polymerase chain reaction. Disease activity and clinical manifestations were determined in RA patients with and without markers of B19 infection.

Results

IgM anti-B19-specific antibodies were detected in 24.0% of RA patients; B19 DNA was found in plasma and/or PBL, synovial fluid cells in 34.0% (34 patients); in 14.0% of the cases (14 patients) both markers were found. In blood donor controls, anti-B19 IgM antibodies were observed in 16.0% (15 donors) and B19 DNA in 6.4% (6 donors); all donors with detectable B19 genomic DNA were IgM-positive. The disease activity in patients with and without B19 infection was similar, while the frequency of clinical complications was significantly higher in the patients with anti-B19 IgM antibodies. Moreover, liver failure and sicca syndrome were observed in the viremic patients only.

Conclusion

Our study confirms observations regarding a high prevalence of B19 DNA in patients with RA, and a possible role of this viral infection in the pathogenesis of RA.

Key Indexing Terms:
  • HUMAN PARVOVIRUS B19
  • RHEUMATOID ARTHRITIS
  • PREVALENCE
  • DISEASE ACTIVITY
  • LIVER FAILURE

Footnotes

  • Supported by grant 04.1155 of the Latvian Science Council to Dr. Murovska.

  • S.V. Kozireva, PhD, Principal Investigator; J.V. Zestkova, PhD Student, Assistant, Department of Oncovirology, August Kirchenstein Institute of Microbiology and Virology; H.J. Mikazane, MD, PhD, Professor, Head of Centre, Department of Inner Diseases, Riga Stradins University, Riga Eastern Hospital; A.L. Kadisa, MD, Assistant, Department of Oncovirology, August Kirchenstein Institute of Microbiology and Virology, Department of Inner Diseases, Riga Stradins University, Riga Eastern Hospital; N.A. Kakurina, MD, PhD Student, Head, Department of Inner Diseases, Riga Stradins University, Riga Eastern Hospital; A.A. Lejnieks, MD, PhD, Professor, Head Doctor, Department of Inner Diseases, Riga Stradins University, Riga Eastern Hospital; I.N. Danilane, MD, Head of Department, State Blood Donor Center; M.F. Murovska, MD, PhD, Director, Department of Oncovirology, August Kirchenstein Institute of Microbiology and Virology.

    • Accepted for publication February 14, 2007.
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 35, Issue 7
1 Jul 2008
  • Table of Contents
  • Index by Author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Incidence and Clinical Significance of Parvovirus B19 Infection in Patients with Rheumatoid Arthritis
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Incidence and Clinical Significance of Parvovirus B19 Infection in Patients with Rheumatoid Arthritis
SVETLANA V. KOZIREVA, JEKATERINA V. ZESTKOVA, HELENA J. MIKAZANE, ANDA L. KADISA, NATALJA A. KAKURINA, AIVARS A. LEJNIEKS, IRENA N. DANILANE, MODRA F. MUROVSKA
The Journal of Rheumatology Jul 2008, 35 (7) 1265-1270;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Incidence and Clinical Significance of Parvovirus B19 Infection in Patients with Rheumatoid Arthritis
SVETLANA V. KOZIREVA, JEKATERINA V. ZESTKOVA, HELENA J. MIKAZANE, ANDA L. KADISA, NATALJA A. KAKURINA, AIVARS A. LEJNIEKS, IRENA N. DANILANE, MODRA F. MUROVSKA
The Journal of Rheumatology Jul 2008, 35 (7) 1265-1270;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • References
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • One-Third of European Patients with Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment
  • Oral Antiviral Treatment for COVID-19 in Patients With Systemic Autoimmune Rheumatic Diseases
  • The Positive Predictive Value of a Very High Serum IgG4 Concentration for the Diagnosis of IgG4-Related Disease
Show more Article

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire